Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
NE NEO NEOGENOMICS INC FY ended Feb 13, 2026 | $17.47 | $2.24B | $2.44B | $727.33M | -$35.54M | -$108.03M | -436.75x | 3.09x | — |
FL FLGT Fulgent Genetics, Inc. FY ended Feb 23, 2026 | — | — | — | $322.67M | -$44.83M | -$60.51M | — | — | — |
EX EXAS EXACT SCIENCES CORP FY ended Feb 12, 2026 | — | — | — | $3.25B | $37.14M | -$207.95M | — | — | — |
NT NTRA Natera, Inc. FY ended Feb 20, 2026 | $325.83 | $46.97B | $46.80B | $2.31B | -$223.62M | -$208.16M | -214.36x | 20.37x | — |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | — | 0/4 | — | — | No saved peers have usable coverage for this method. |
Price / Sales PSActive | Equity Multiple | 11.73x | 2/4 | $11.52B | $85.81 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | -325.56x | 2/4 | $135.52B | $1,009.88 | Peer averages are not economically meaningful for this method. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
NE NEO NEOGENOMICS INC FY ended Feb 13, 2026 | $17.47 | $2.24B | $2.44B | $727.33M | -$35.54M | -$108.03M | -436.75x | 3.09x | — |
FL FLGT Fulgent Genetics, Inc. FY ended Feb 23, 2026 | — | — | — | $322.67M | -$44.83M | -$60.51M | — | — | — |
EX EXAS EXACT SCIENCES CORP FY ended Feb 12, 2026 | — | — | — | $3.25B | $37.14M | -$207.95M | — | — | — |
NT NTRA Natera, Inc. FY ended Feb 20, 2026 | $325.83 | $46.97B | $46.80B | $2.31B | -$223.62M | -$208.16M | -214.36x | 20.37x | — |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | — | 0/4 | — | — | No saved peers have usable coverage for this method. |
Price / Sales PSActive | Equity Multiple | 11.73x | 2/4 | $11.52B | $85.81 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | -325.56x | 2/4 | $135.52B | $1,009.88 | Peer averages are not economically meaningful for this method. |